Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD

Background Respiratory virus infections are commonly associated with COPD exacerbations, but little is known about the mechanisms linking virus infection to exacerbations. Pathogenic mechanisms in stable COPD include oxidative and nitrosative stress and reduced activity of histone deacetylase-2 (HDAC2), but their roles in COPD exacerbations is unknown. We investigated oxidative and nitrosative stress (O&NS) and HDAC2 in COPD exacerbations using experimental rhinovirus infection. Methods Nine subjects with COPD (Global Initiative for Chronic Obstructive Lung Disease stage II), 10 smokers, and 11 nonsmokers were successfully infected with rhinovirus. Markers of O&NS-associated cellular damage, and inflammatory mediators and proteases were measured in sputum, and HDAC2 activity was measured in sputum and bronchoalveolar macrophages. In an in vitro model, monocyte-derived THP-1 cells were infected with rhinovirus and nitrosylation and activity of HDAC2 was measured. Results Rhinovirus infection induced significant increases in airways inflammation and markers of O&NS in subjects with COPD. O&NS markers correlated with virus load and inflammatory markers. Macrophage HDAC2 activity was reduced during exacerbation and correlated inversely with virus load, inflammatory markers, and nitrosative stress. Sputum macrophage HDAC2 activity pre-infection was inversely associated with sputum virus load and inflammatory markers during exacerbation. Rhinovirus infection of monocytes induced nitrosylation of HDAC2 and reduced HDAC2 activity; inhibition of O&NS inhibited rhinovirus-induced inflammatory cytokines. Conclusions O&NS, airways inflammation, and impaired HDAC2 may be important mechanisms of virus-induced COPD exacerbations. Therapies targeting these mechanisms offer potential new treatments for COPD exacerbations.

[1]  S. Johnston,et al.  Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease☆ , 2014, Respiratory medicine.

[2]  J. Walters,et al.  Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. , 2003, The Cochrane database of systematic reviews.

[3]  S. Johnston,et al.  Neutrophil adhesion molecules in experimental rhinovirus infection in COPD , 2013, Respiratory Research.

[4]  P. Barnes Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. , 2013, The Journal of allergy and clinical immunology.

[5]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[6]  S. Johnston,et al.  Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[7]  F. Maltais,et al.  TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial , 2012, Thorax.

[8]  Christopher E Brightling,et al.  Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. , 2012, American journal of respiratory and critical care medicine.

[9]  C. Vogelmeier,et al.  A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium , 2012, COPD.

[10]  S. Johnston,et al.  Viruses exacerbating chronic pulmonary disease: the role of immune modulation , 2012, BMC Medicine.

[11]  M. Furue,et al.  Role of the Arylhydrocarbon Receptor (AhR) in the Pathology of Asthma and COPD , 2012, Journal of allergy.

[12]  B. Fischer,et al.  Pathogenic triad in COPD: oxidative stress, protease–antiprotease imbalance, and inflammation , 2011, International journal of chronic obstructive pulmonary disease.

[13]  B. Cosío,et al.  Mecanismos moleculares de inflamación durante las agudizaciones de la enfermedad pulmonar obstructiva crónica , 2011 .

[14]  S. Johnston,et al.  Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. , 2011, American journal of respiratory and critical care medicine.

[15]  A. Agustí,et al.  Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. , 2011, Archivos de bronconeumologia.

[16]  I. Adcock,et al.  Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[17]  Kazuhiro Ito,et al.  Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. , 2009, Biochemical and biophysical research communications.

[18]  K. Kostikas,et al.  Clinical, functional and biochemical changes during recovery from COPD exacerbations. , 2009, Respiratory medicine.

[19]  A. Agustí,et al.  Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD , 2009, Thorax.

[20]  P. Calverley,et al.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.

[21]  Hongwei Yao,et al.  Future therapeutic treatment of COPD: Struggle between oxidants and cytokines , 2007, International journal of chronic obstructive pulmonary disease.

[22]  S. Rennard,et al.  The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[23]  R. Rodríguez-Roisín,et al.  Antibiotics for exacerbations of chronic obstructive pulmonary disease. , 2011, The Cochrane database of systematic reviews.

[24]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[25]  S. Johnston,et al.  An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study , 2006, Respiratory research.

[26]  S. Johnston,et al.  Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. , 2006, American journal of respiratory and critical care medicine.

[27]  S. Rennard,et al.  Reactive nitrogen species augment fibroblast-mediated collagen gel contraction, mediator production, and chemotaxis. , 2006, American journal of respiratory cell and molecular biology.

[28]  R. Djukanović,et al.  Inflammatory cells in the airways in COPD , 2006, Thorax.

[29]  I. Adcock,et al.  Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.

[30]  R. Pauwels,et al.  Matrix metalloproteinases in asthma and COPD. , 2005, Current opinion in pharmacology.

[31]  N. Siafakas,et al.  Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. , 2005, Chest.

[32]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[33]  J. Roca,et al.  Oxidative stress and airway inflammation in severe exacerbations of COPD , 2005, Thorax.

[34]  L. Tamer,et al.  N-acetylcysteine inhibits peroxynitrite-mediated damage in oleic acid-induced lung injury. , 2004 .

[35]  M. Tabrizi,et al.  Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study. , 2004, Chest.

[36]  David E Levy,et al.  Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[38]  I. Adcock,et al.  Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.

[39]  P. Barnes,et al.  Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD , 2003, Thorax.

[40]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[41]  N. Anthonisen,et al.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.

[42]  T. Seemungal,et al.  Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease , 2001, Thorax.

[43]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[44]  K. Hirata,et al.  Inhibition of bronchoprotective effects of beta2-adrenoceptor agonists by peroxynitrite in guinea pig airways. , 1999, American journal of respiratory and critical care medicine.

[45]  E. Niki,et al.  Peroxynitrite‐induced hemolysis of human erythrocytes and its inhibition by antioxidants , 1997, FEBS letters.

[46]  K. Aben,et al.  Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[47]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.